Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009599
Filing Date
2025-05-12
Accepted
2025-05-12 11:57:40
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 639225
2 EX-31.1 ex31-1.htm EX-31.1 20914
3 EX-32.1 ex32-1.htm EX-32.1 8502
4 GRAPHIC form10-q_001.jpg GRAPHIC 28235
  Complete submission text file 0001641172-25-009599.txt   4310471

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gcan-20250331.xsd EX-101.SCH 33417
6 XBRL CALCULATION FILE gcan-20250331_cal.xml EX-101.CAL 32854
7 XBRL DEFINITION FILE gcan-20250331_def.xml EX-101.DEF 174084
8 XBRL LABEL FILE gcan-20250331_lab.xml EX-101.LAB 297098
9 XBRL PRESENTATION FILE gcan-20250331_pre.xml EX-101.PRE 251473
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 525354
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56027 | Film No.: 25933699
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)